Drugs / GCC2005
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06699771 | Mar 2025 → Apr 2026 overdue | T-cell non-Hodgkin lymphoma | GC Cell Corporation | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GCC2005 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06699771 ↗ |
| Modality | Cell therapy | “CAR-NK Cell Therapy” NCT06699771 ↗ |